Tekla Life Sciences Investors

Location

Massachusetts

Founded

2000-01-26

Website

https://www.teklacap.com

Risk Signals

155 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Management Investment Offices, Open-End), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Stock Market Events (128) Investment Strategies (101) Equity Analysis & Ratings (42) Acquisition Announcements (36) Earnings Reports & Warnings (36) Issuing Shares (34) Stock Buyback (34) Financial Reporting (18) Corporate Deals (18) Inter-Organizational Collaborations (17) Regulatory Updates (17) Asset Divestment (16) Shareholders Feedback (15) Offshore Tax Practices (14) Capital Funding Requests (7) Funding Announcements (6) Business Growth Initiatives (5) Corporate Governance Policies (4) Workforce Reductions (2) Corporate Restructuring (2) Credit Rating Updates (2) Illicit Financial Practices (2) Initial Public Offering Launch (2) New Product Release (2) Access and Affordability Initiatives (2) Legal and Regulatory Management (1) Corporate Rebranding (1) Competitive Market Dynamics (1) Climate Change Effects (1) Material Supply Trends (1)

Recent Articles about Tekla Life Sciences Investors

Live alerts from global media, monitored by Business Radar

2023-09-29 (marketbeat.com)

Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)

Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s

2016-08-06 (teklacap.com)